CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells

por Fontanella, Rosaria A., Sideri, Silvia, Di Stefano, Chiara, Catizone, Angiolina, Di Agostino, Silvia, Angelini, Daniela F., Guerrera, Gisella, Battistini, Luca, Battafarano, Giulia, Del Fattore, Andrea, Campese, Antonio Francesco, Padula, Fabrizio, De Cesaris, Paola, Filippini, Antonio, Riccioli, Anna
Publicado 2021

Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma

por Dolgova, Evgeniya V., Andrushkevich, Oleg M., Kisaretova, Polina E., Proskurina, Anastasia S., Ritter, Genrikh S., Dubatolova, Tatyana D., Romanenko, Margarita V., Taranov, Oleg S., Efremov, Yaroslav R., Zavyalov, Evgeniy L., Romaschenko, Alexandr V., Mishinov, Sergey V., Kirikovich, Svetlana S., Levites, Evgeniy V., Potter, Ekaterina A., Ostanin, Alexandr A., Chernykh, Elena R., Roshchin, Stanislav Yu., Bervitskiy, Anatoliy V., Moysak, Galina I., Rzaev, Jamil A., Bogachev, Sergey S.
Publicado 2021

A breakthrough in liver regeneration for treatment of liver cancer

por Xu, Hao, Pan, Yisheng, Zhang, Ning
Publicado 2021

Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer

por Hu, Nanlin, Si, Yiran, Yue, Jian, Sun, Tingting, Wang, Xue, Jia, Zhuqing, Gao, Songlin, Li, Qiao, Shao, Yang, Wang, Jiayu, Luo, Yang, Ma, Fei, Xu, Binghe, Yuan, Peng
Publicado 2021

Current research on circular RNAs and their potential clinical implications in breast cancer

por Liu, Diya, Fang, Lin
Publicado 2021

Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial

por Chu, Tianqing, Lu, Jun, Bi, Minghong, Zhang, Helong, Zhuang, Wu, Yu, Yan, Shi, Jianhua, Chen, Zhendong, Zhang, Xiaochun, Guo, Qisen, Liu, Quan, Wu, Huijuan, Fang, Jian, Hu, Yi, Wang, Xiuwen, Han, Cuicui, Li, Kai, Han, Baohui
Publicado 2021

Development and validation of a risk model for noninvasive detection of cancer in oral potentially malignant disorders using DNA image cytometry

por Li, Chenxi, Zhou, Yongmei, Deng, Yiwen, Shen, Xuemin, Shi, Linjun, Liu, Wei
Publicado 2021

NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma

por Yue, Dongli, Liu, Shasha, Zhang, Tengfei, Wang, Yong, Qin, Guohui, Chen, Xinfeng, Zhang, Huanyu, Wang, Dong, Huang, Lan, Wang, Feng, Wang, Liping, Zhao, Song, Zhang, Yi
Publicado 2021

Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients

por He, Yongqiao, Yang, Dawei, Zhou, Ting, Xue, Wenqiong, Zhang, Jiangbo, Li, Fangfang, Wang, Fang, Wang, Tongmin, Wu, Ziyi, Liao, Ying, Zheng, Meiqi, Deng, Changmi, Li, Danhua, Jia, Yijing, Yuan, Leilei, Zhang, Wenli, Jia, Weihua
Publicado 2021

Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver

por Ye, Xiangdong, Wang, Xueqing, Yu, Wenhui, Yang, Qing, Li, Yan, Jin, Yanxia, Su, Yanting, Song, Jiaqi, Xu, Bo, Sun, Hui
Publicado 2021

Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

por Xu, Zhengli, Huang, Xiaojun
Publicado 2021

Cyclophosphamide abrogates the expansion of CD4(+)Foxp3(+) regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas

por Li, Ping, Chen, Fengyang, Zheng, Jingbin, Yang, Yang, Li, Yuan, Wang, Yifei, Chen, Xin
Publicado 2021

Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers

por Yu, Yingyan
Publicado 2021

Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers

por Yu, Huahui, Li, Jieyu, Yuan, Yuan, Chen, Yu, Hong, Jingwen, Ye, Chunmei, Lin, Wansong, Chen, Huijing, Guo, Zengqing, Li, Bo, Ye, Yunbin
Publicado 2021

Cancer immunology and immunotherapy

por Ren, Xiubao
Publicado 2021

The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma

por Wang, Jian, Yang, Fan, Sun, Qian, Zeng, Ziqing, Liu, Min, Yu, Wenwen, Zhang, Peng, Yu, Jinpu, Yang, Lili, Zhang, Xinwei, Ren, Xiubao, Wei, Feng
Publicado 2021

Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types

por Gong, Zhe, Yang, Yue, Zhang, Jieyun, Guo, Weijian
Publicado 2021

Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy

por Gong, Ruining, Huang, Yan, Wang, Xiaoxuan, Chen, Xiaobing, Tian, Zibin, Ren, He
Publicado 2021

Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies

por Han, Lu, Zhou, Jian, Li, Linlin, Zhou, Keshu, Zhao, Lingdi, Zhu, Xinghu, Yin, Qingsong, Li, Yufu, You, Hongqin, Zhang, Jishuai, Song, Yongping, Gao, Quanli
Publicado 2021

Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells

por Sun, Yunfan, Zhou, Jian, Fan, Jia, Yang, Xinrong
Publicado 2021